drugset
Drugs / Huoluo Pills
last change 4 days ago re-read 2 minutes ago

Huoluo Pills

Developed for
rheumatoid arthritis
Investigated by
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine · Affiliated Hospital of Shandong University of Traditional Chinese Medicine · Beijing Leadingpharm Medicine Technology Development · Institute of Science, Beijing Tongrentang Co., Ltd. · Shaanxi Hospital of Traditional Chinese Medicine · Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
+4 more · The First Affiliated Hospital of Henan university of CM · The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine · Wangjing Hospital, China Academy of Chinese Medical Sciences · Xi'an No.5 Hospital

Trials 1 · a red edge is where a trial was stopped

today NCT07115641 · not/applicable
2026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT07115641 Aug 2025 → May 2026 overdue rheumatoid arthritis Wangjing Hospital, China Academy of Chinese Medical Sciences Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Huoluo Pills ClinicalTrials.gov intervention name — accepted as the source's own label NCT07115641 ↗
Route Oral “Orally take 1 pill once, twice a day” NCT07115641 ↗